12/20/2024Sustainability
12/19/2024Corporate
Notice of Change of Directors and Officers(PDF:111.3 KB)
12/19/2024Corporate
Appointment of Director(PDF:175.2 KB)
12/19/2024Corporate
JSR Receives High Praise from NEDO's “Pioneering Research Program for Materials Innovation”
12/12/2024Corporate
Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership
12/02/2024Corporate
Notice Regarding the Merger
11/22/2024Corporate
JSR at SEMICON JAPAN 2024
11/14/2024Financial
First Half of Fiscal Year Ending March 31 2025 Business Status Briefing Materials
11/13/2024Corporate
Combining optical and magnetic technologies to realize a new photomedical technology-JSR Corporation and Illumi Medical, Inc. sign a joint research agreement-
11/12/2024Corporate
Notice of Spin-off of ETEC and Transfer of Shares
11/05/2024Corporate
JSR Issues JSR Report 2024
10/31/2024Corporate
Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test
09/17/2024Products
JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification
09/12/2024Corporate
Metagen Therapeutics and JSR, Alliance to Establish Microbiome Medicine Investigational Drug Manufacturing Facility ~ Scheduled to be operational by end of 2025 for start of clinical trials in Japan and overseas~
09/09/2024Corporate
Appointment of Auditors
09/02/2024Corporate
Notice of Expected Merger Date
08/30/2024Corporate
JSR Expands Global Development and Production Functions for Leading-Edge Photoresists
08/26/2024Products
MBL received MHLW approval for its MEBGEN™ mycobacterial nucleic acid identification kit
08/21/2024Corporate
JSR Succeeds in Developing Biomimetic Smart Plastic Materials for Precise Recognition of Antibodies
08/02/2024Corporate
JSR Completes Acquisition of All Shares in Yamanaka Hutech ~ Accelerating Semiconductor Materials Industry Reorganization~
07/24/2024Corporate
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
07/22/2024Financial
Annual Report 2024(PDF:12.7 MB)
07/09/2024Financial
JSR・JICC Joint Press Conference(QA Summary)(PDF:393.9 KB)
07/09/2024Financial
JSR・JICC Joint Press Conference(Video)
07/03/2024Corporate
Appointment of Directors and Auditors(Revised)
06/27/2024Corporate
Appointment of Directors and Auditors
06/24/2024Financial
Announcement of Delisting of Shares of JSR Corporation(PDF:173.2 KB)
06/14/2024Financial
Notice of Submission of Extraordinary Report relating to the matters resolved and the voting results thereof at the Extraordinary General Meeting of Shareholders of JSR Corporation(PDF:198.7 KB)
06/10/2024Corporate
JSR's Low Dielectric Resin “ELPAC™ HC-G Series“ won The 20th JPCA Award!
06/05/2024Corporate
Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies
06/05/2024Corporate
Crown Bioscience Enters Global Agreement with Shanghai Model Organism Center
06/05/2024Financial
Notice regarding Approval for Resolutions Related to Reverse Stock Split etc.(PDF:199.5 KB)
05/28/2024Corporate
JSR at JPCA Show 2024
05/16/2024Corporate
JSR to make Yamanaka Hutech, a high-purity chemical for semiconductors, a wholly owned subsidiary ~Expanding the product portfolio in the field of cutting-edge semiconductor deposition~
05/14/2024Financial
Notice of Convening of the Extraordinary General Meeting of Shareholders(PDF:452.0 KB)
05/13/2024Financial
Summary of Q&A session of Conference call(PDF:84.5 KB)
05/08/2024Financial
Notice of Change of Directors and Officers(PDF:179.3 KB)
05/08/2024Financial
Notice regarding Transfer of Representative Directors(PDF:109.2 KB)
05/08/2024Financial
Announcement of Cancellation of Treasury Stock(PDF:109.9 KB)
05/08/2024Financial
Notice Concerning Reverse Stock Split, Abolition of the Share Number Unit,and Partial Amendments to the Articles of Incorporation(PDF:347.6 KB)
04/30/2024Financial
Briefing Video on Financial Results
04/30/2024Financial
Minutes(PDF:222.3 KB)
04/30/2024Financial
Notice regarding Difference between Forecasts and Actual Results for the Fiscal Year Ended March 31, 2024(PDF:211.8 KB)
04/30/2024Financial
Consolidated Financial Results for the year ended March 2024(PDF:1.0 MB)
04/30/2024Financial
JSR 23Q4_Presentation Material for earnings announcement(PDF:559.0 KB)
04/25/2024Products
JSR Group's Techno UMG receives ISCC PLUS Certification at Ube Plant
04/24/2024Sustainability
Support for the people and areas affected by the 2024 Taiwan East Coast Earthquake
04/17/2024Financial
Notice Concerning Results of the Tender Offer And Change of Parent Company and Largest Major Shareholder(PDF:418.8 KB)
04/09/2024Corporate
Update regarding Lawsuit Filed by SUNY against Inpria Corporation and JSR Corporation Court Denied SUNY’s Motion for a Temporary Restraining Order and Preliminary Injunction
04/08/2024Financial
Announcement of Record Date for Convocation of Extraordinary General Meeting of Shareholders(PDF:165.4 KB)
03/18/2024Financial
Announcement Regarding Commencement of Tender Offer for JSR Corporation (Securities Code 4185) by JICC-02, Ltd.(PDF:920.8 KB)
03/18/2024Financial
Announcement of Opinion on the Tender Offer and Recommendation for our Shareholders to Tender their Shares in the Tender Offer to be Conducted by JICC(PDF:461.7 KB)
03/14/2024Corporate
JSR Response to Media Articles Regarding Progress of the Tender Offer for Our Shares
03/04/2024Corporate
JSR Response to Media Articles Regarding Progress of the Tender Offer for Our Shares
02/21/2024Financial
Summary of Q&A session of Conference call(PDF:164.0 KB)
02/06/2024Financial
Minutes(PDF:259.4 KB)
02/05/2024Financial
Briefing Video on Financial Results
02/05/2024Financial
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024 (under IFRS)(PDF:456.8 KB)
02/05/2024Financial
JSR 23Q3_Presentation Material for earnings announcement(PDF:632.9 KB)
02/02/2024Corporate
Notice of Lawsuit Filing in the United States against Inpria Corporation, a wholly owned subsidiary of JSR, and JSR
01/24/2024Sustainability
Support for the people and areas affected by the Noto Peninsula Earthquake
01/19/2024Corporate
JSR at INTER NEPCON JAPAN 2024
01/17/2024Corporate
KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies
01/10/2024Corporate
JSR Active Innovation Fund LLC invests in Aillis, Inc., which develops and sells AI medical devices
01/01/2024Corporate